These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8999549)

  • 1. Reverse transcriptase fidelity and HIV-1 variation.
    Preston BD
    Science; 1997 Jan; 275(5297):228-9; author reply 230-1. PubMed ID: 8999549
    [No Abstract]   [Full Text] [Related]  

  • 2. Reverse transcriptase fidelity and HIV-1 variation.
    Keulen W; Nijhuis M; Schuurman R; Berkhout B; Boucher C
    Science; 1997 Jan; 275(5297):229; author reply 230-1. PubMed ID: 8999550
    [No Abstract]   [Full Text] [Related]  

  • 3. Reverse transcriptase fidelity and HIV-1 variation.
    Balzarini J; Pelemans H; De Clercq E; Karlsson A; Kleim JP
    Science; 1997 Jan; 275(5297):229-30; author reply 230-1. PubMed ID: 8999551
    [No Abstract]   [Full Text] [Related]  

  • 4. A fossil record of zidovudine resistance in transmitted isolates of HIV-1.
    Kuritzkes DR
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13485-7. PubMed ID: 11717419
    [No Abstract]   [Full Text] [Related]  

  • 5. Lamivudine resistance of HIV type 1 does not delay development of resistance to nonnucleoside HIV type 1-specific reverse transcriptase inhibitors as compared with wild-type HIV type 1.
    Jonckheere H; Witvrouw M; De Clercq E; Anné J
    AIDS Res Hum Retroviruses; 1998 Feb; 14(3):249-53. PubMed ID: 9491915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V.
    Hertogs K; Bloor S; De Vroey V; van Den Eynde C; Dehertogh P; van Cauwenberge A; Stürmer M; Alcorn T; Wegner S; van Houtte M; Miller V; Larder BA
    Antimicrob Agents Chemother; 2000 Mar; 44(3):568-73. PubMed ID: 10681319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
    Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
    J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiretroviral Resistance Mutations (revised April 2001).
    ;
    HIV Clin Trials; 2001; 2(4):346-55. PubMed ID: 11590539
    [No Abstract]   [Full Text] [Related]  

  • 9. Closing in on HIV drug resistance.
    Larder BA; Stammers DK
    Nat Struct Biol; 1999 Feb; 6(2):103-6. PubMed ID: 10048915
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of drug resistance associated mutations in HIV primary infection within the UK.
    Pillay D; Cane PA; Shirley J; Porter K
    AIDS; 2000 May; 14(7):906-8. PubMed ID: 10839606
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of reverse transcriptase mutations associated with HIV-1 drug resistance mainly against non-nucleoside reverse transcriptase inhibitors in treatment-naive patients.
    Magiorkinis E; Paraskevis D; Lazanas M; Kiosses VG; Gargalianos P; Hatzakis A
    AIDS; 1999 Jul; 13(10):1276-8. PubMed ID: 10416535
    [No Abstract]   [Full Text] [Related]  

  • 12. Increasing prevalence of HIV-1 reverse transcriptase mutation K65R correlates with tenofovir utilization.
    Kagan RM; Merigan TC; Winters MA; Heseltine PN
    Antivir Ther; 2004 Oct; 9(5):827-8. PubMed ID: 15535422
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of primary resistance to zidovudine and lamivudine in drug-naive human immunodeficiency virus type-1 infected patients: high proportion of reverse transcriptase codon 215 mutant in circulating lymphocytes and free virus.
    Trabaud MA; Leriche-Guerin K; Regis C; Bordes I; Cotte L; Detmer J; Kolberg J; Ritter J; Trépo C
    J Med Virol; 2000 Jul; 61(3):352-9. PubMed ID: 10861645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased polymerase fidelity of lamivudine-resistant HIV-1 variants does not limit their evolutionary potential.
    Keulen W; van Wijk A; Schuurman R; Berkhout B; Boucher CA
    AIDS; 1999 Jul; 13(11):1343-9. PubMed ID: 10449287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. R211K and L214F do not invariably confer high level phenotypic resistance to thymidine analogs in zidovudine-naive patients with M184V.
    Torti C; Gilleece Y; Hertogs K; Gazzard BG; Pozniak AL
    J Acquir Immune Defic Syndr; 2001 Apr; 26(5):514-5. PubMed ID: 11391177
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.
    Gómez-Cano M; Rubio A; Puig T; Pérez-Olmeda M; Ruiz L; Soriano V; Pineda JA; Zamora L; Xaus N; Clotet B; Leal M
    AIDS; 1998 Jun; 12(9):1015-20. PubMed ID: 9662197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to (-)-2',3'-dideoxy-3'-thiacytidine (3TC) in HIV-1 isolated from paediatric patients.
    Wainberg MA; Lewis L; Salomon H; Gu Z; Keller A; Cammack N; Goldsmith J; Church J; Spira B; Wheeler S; Pizzo P
    Antivir Ther; 1996 Apr; 1(2):98-104. PubMed ID: 11321185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary lamivudine resistance in acute/early human immunodeficiency virus infection.
    Conway B; Montessori V; Rouleau D; Montaner JS; O'Shaughnessy MV; Fransen S; Shillington A; Weislow O; Mayers DL
    Clin Infect Dis; 1999 Apr; 28(4):910-1. PubMed ID: 10825060
    [No Abstract]   [Full Text] [Related]  

  • 19. Current insights into reverse transcriptase inhibitor-associated resistance.
    Wainberg MA; White AJ
    Antivir Ther; 2001; 6 Suppl 2():11-9. PubMed ID: 11678474
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective expansion of a minor proportion of drug-resistant HIV-1 by antiretroviral pressure in vitro.
    Roberts BD; Pau CP; Weinstock H; Heneine W; Butera ST
    AIDS; 2000 Dec; 14(17):2797-8. PubMed ID: 11125904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.